<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04480203</url>
  </required_header>
  <id_info>
    <org_study_id>CABC - Kreftfor project - SEB</org_study_id>
    <nct_id>NCT04480203</nct_id>
  </id_info>
  <brief_title>Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions</brief_title>
  <acronym>CABC</acronym>
  <official_title>Coping After Breast Cancer - CABC - Stressmestring Etter Brystkreft - SEB</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cancer Registry of Norway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cancer Registry of Norway</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Breast cancer patients and age-matched controls are first invited to answer questions on&#xD;
           HRQoL.&#xD;
&#xD;
        2. Among responding breast cancer patients, a subset are invited in a randomized clinical&#xD;
           trial with two digital interventions for cancer stress management, cognitive based&#xD;
           stress management (CBSM) and mindfulness based intervention (MBI), as well as a control&#xD;
           group.&#xD;
&#xD;
        3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress&#xD;
           levels as compared to a control group. Second, whether these interventions can improve&#xD;
           HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a&#xD;
           control group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After completing the baseline HRQoL assessment, eligible breast cancer patients will be&#xD;
      invited to participate in a randomized clinical trial.&#xD;
&#xD;
      Those who are willing will be randomly allocated to one of the following arms: a) Digital&#xD;
      cognitive based stress management, b) Digital mindfulness based intervention or c) Control&#xD;
      group.&#xD;
&#xD;
      The intervention is based on a revised version of the Stressproffen app, which was developed&#xD;
      by the Oslo University Hospital (Lise Solberg Nes, Elin Børøsund and others).&#xD;
&#xD;
      Outcome measures include measures of perceived stress and HRQoL.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2035</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>An intervention study of breast cancer patients with two digital intervention arms and one control group.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Only the staff that have contact with the participants will know who receives which intervention. The statistician and investigators will be masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Stress</measure>
    <time_frame>change from CABC baseline (week 0) to f-up week 21</time_frame>
    <description>Cohens perceived stress scale. Unit is summary score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective health (HRQoL)</measure>
    <time_frame>change from CABC baseline (week 0) to f-up week 21</time_frame>
    <description>RAND-36 questionnaire. Unit is summary score and module-specific scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Coping</measure>
    <time_frame>change from CABC baseline (week 0) to f-up week 21</time_frame>
    <description>TOMCATS questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>change from CABC baseline (week 0) to f-up week 21</time_frame>
    <description>PHQ-4 questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>change from CABC baseline (week 0) to f-up week 21</time_frame>
    <description>Chalders' fatigue questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindfulness</measure>
    <time_frame>change from CABC baseline (week 0) to f-up week 21</time_frame>
    <description>Baer 2006 mindfulness questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>change from CABC baseline (week 0) to f-up week 21</time_frame>
    <description>selected questions fro SUSSH questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EORTC QLQ-C30</measure>
    <time_frame>From NBCR baseline to f-up week 20</time_frame>
    <description>EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EORTC QLQ-BR23</measure>
    <time_frame>From NBCR baseline to f-up week 20</time_frame>
    <description>EORTC breast cancer questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropathy (FACT GOG-NTX and -ES)</measure>
    <time_frame>From NBCR baseline to f-up week 20</time_frame>
    <description>neuropathy questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 15</time_frame>
    <description>Cohens perceived stress scale. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective health (HRQoL)</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 15</time_frame>
    <description>RAND-36 questionnaire. Unit is summary score and module-specific scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 15</time_frame>
    <description>TOMCATS questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 15</time_frame>
    <description>Chalders' fatigue questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindfulness</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 15</time_frame>
    <description>Baer 2006 mindfulness questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 15</time_frame>
    <description>PHQ-4 questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 15</time_frame>
    <description>selected questions fro SUSSH questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work</measure>
    <time_frame>status at f-up month 15</time_frame>
    <description>questions on employment. Whether employed and percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 27</time_frame>
    <description>Cohens perceived stress scale. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective health (HRQoL)</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 27</time_frame>
    <description>RAND-36 questionnaire. Unit is summary score and module-specific scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 27</time_frame>
    <description>TOMCATS questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 27</time_frame>
    <description>PHQ-4 questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 27</time_frame>
    <description>Chalders' fatigue questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindfulness</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 27</time_frame>
    <description>Baer 2006 mindfulness questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>change from CABC baseline (week 0) to f-up month 27</time_frame>
    <description>selected questions fro SUSSH questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EORTC QLQ-C30</measure>
    <time_frame>change from NBCR baseline to f-up month 27</time_frame>
    <description>EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EORTC QLQ-BR23</measure>
    <time_frame>change from NBCR baseline to f-up month 27</time_frame>
    <description>EORTC breast cancer questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropathy (FACT GOG-NTX and -ES)</measure>
    <time_frame>From NBCR baseline to f-up month 27</time_frame>
    <description>neuropathy questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">390</enrollment>
  <condition>Breast Cancer Patients</condition>
  <condition>Health, Subjective</condition>
  <arm_group>
    <arm_group_label>Cognitive based stress management (CBSM)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cognitive based digital intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness based intervention (MBI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mindfulness based digital intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control arm. No intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stressproffen cognitive based stress management</intervention_name>
    <description>The participants will download an app (Stressproffen 2A) with cognitive based stress management.</description>
    <arm_group_label>Cognitive based stress management (CBSM)</arm_group_label>
    <other_name>CBSM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stressproffen mindfulness based intervention</intervention_name>
    <description>The participants will download an app (Stressproffen 2B) with mindfulness based intervention.</description>
    <arm_group_label>Mindfulness based intervention (MBI)</arm_group_label>
    <other_name>MBI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>The participants will receive no app. (They will be able to download it after the end of the 3 year study).</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  first occurrence breast cancer diagnosed from Jan 1, 2020&#xD;
&#xD;
          -  non-metastatic cancer stage 0-III&#xD;
&#xD;
        Invasive tumors must be:&#xD;
&#xD;
          -  HER2 positive (regardless of ER, PR) or&#xD;
&#xD;
          -  ER negative&#xD;
&#xD;
          -  (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female breast cancer patients</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giske Ursin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cancer Registry of Norway</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giske Ursin, MD, PhD</last_name>
    <phone>+4722451300</phone>
    <email>giske.ursin@kreftregisteret.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ine M Larsson</last_name>
    <phone>+4722928985</phone>
    <email>ine.marie.larsson@kreftregisteret.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cancer Registry of Norway</name>
      <address>
        <city>Oslo</city>
        <zip>0379</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giske Ursin</last_name>
      <phone>+47 22928701</phone>
      <email>giske.ursin@kreftregisteret.no</email>
    </contact>
    <contact_backup>
      <last_name>Ine Marie Larsson</last_name>
      <phone>+4722928985</phone>
      <email>ine.marie.larsson@kreftregisteret.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>July 9, 2020</study_first_submitted>
  <study_first_submitted_qc>July 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2020</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Health Related Quality of Life</keyword>
  <keyword>Stress management intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 6, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/03/NCT04480203/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

